Clinical Trial Update: Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pembrolizumab with locally delivered radiation therapy for metastatic esophageal cancer has completed enrollment, and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Esophageal Cancer, Cancer of the Esophagus | Phase 1 | Status: COMPLETED | Results posted: 2026-03-18